K945854

Substantially Equivalent

B-FACT, BORDERLINE FACTOR ASSAY CONTROL

Applicant: George King Bio-Medical, Inc.
Product code: GGN
Advisory panel: Hematology
Date received: 1994-11-14
Decision date: 1995-10-24
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Overland Park, KS, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.